This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Topisirovic, I.
Right arrow Articles by Borden, K. L. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Topisirovic, I.
Right arrow Articles by Borden, K. L. B.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, December 2003, p. 8992-9002, Vol. 23, No. 24
0270-7306/03/$08.00+0     DOI: 10.1128/MCB.23.24.8992-9002.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Aberrant Eukaryotic Translation Initiation Factor 4E-Dependent mRNA Transport Impedes Hematopoietic Differentiation and Contributes to Leukemogenesis

Ivan Topisirovic,1 Monica L. Guzman,2,{dagger} Melanie J. McConnell,3 Jonathan D. Licht,3 Biljana Culjkovic,1 Sarah J. Neering,2,{dagger} Craig T. Jordan,2,{dagger} and Katherine L. B. Borden1*

Structural Biology Program, Department of Physiology and Biophysics,1 Department of Medicine, Mount Sinai School of Medicine, New York University, New York, New York 10029,3 Blood and Marrow Transplant Program, Markey Cancer Center, Division of Hematology Oncology, University of Kentucky Medical Center, Lexington, Kentucky 405362

Received 28 May 2003/ Returned for modification 7 August 2003/ Accepted 15 September 2003

The eukaryotic translation initiation factor 4E (eIF4E) acts as both a key translation factor and as a promoter of nucleocytoplasmic transport of specific transcripts. Traditionally, its transformation capacity in vivo is attributed to its role in translation initiation in the cytoplasm. Here, we demonstrate that elevated eIF4E impedes granulocytic and monocytic differentiation. Our subsequent mutagenesis studies indicate that this block is a result of dysregulated eIF4E-dependent mRNA transport. These studies indicate that the RNA transport function of eIF4E could contribute to leukemogenesis. We extended our studies to provide the first evidence that the nuclear transport function of eIF4E contributes to human malignancy, specifically in a subset of acute and chronic myelogenous leukemia patients. We observe an increase in eIF4E-dependent cyclin D1 mRNA transport and a concomitant increase in cyclin D1 protein levels. The aberrant nuclear function of eIF4E is due to abnormally large eIF4E bodies and the loss of regulation by the proline-rich homeodomain PRH. We developed a novel tool to modulate this transport activity. The introduction of I{kappa}B, the repressor of NF-{kappa}B, leads to suppression of eIF4E, elevation of PRH, reorganization of eIF4E nuclear bodies, and subsequent downregulation of eIF4E-dependent mRNA transport. Thus, our findings indicate that this nuclear function of eIF4E can contribute to leukemogenesis by promoting growth and by impeding differentiation.

* Corresponding author. Mailing address: Department of Physiology and Biophysics, Mount Sinai School of Medicine, New York University, One Gustave Levy Place, New York, NY 10029. Phone: (212) 659-8677. Fax: (212) 849-2456. E-mail: kathy{at}physbio.mssm.edu.

{dagger} Present address: University of Rochester School of Medicine, Rochester, NY 14642.

Molecular and Cellular Biology, December 2003, p. 8992-9002, Vol. 23, No. 24
0022-538X/03/$08.00+0     DOI: 10.1128/MCB.23.24.8992-9002.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Assouline, S., Culjkovic, B., Cocolakis, E., Rousseau, C., Beslu, N., Amri, A., Caplan, S., Leber, B., Roy, D.-C., Miller, W. H. Jr, Borden, K. L. B. (2009). Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin. Blood 114: 257-260 [Abstract] [Full Text]  
  • Soufi, A., Noy, P., Buckle, M., Sawasdichai, A., Gaston, K., Jayaraman, P.-S. (2009). CK2 phosphorylation of the PRH/Hex homeodomain functions as a reversible switch for DNA binding. Nucleic Acids Res 37: 3288-3300 [Abstract] [Full Text]  
  • Topisirovic, I., Siddiqui, N., Orolicki, S., Skrabanek, L. A., Tremblay, M., Hoang, T., Borden, K. L. B. (2009). Stability of Eukaryotic Translation Initiation Factor 4E mRNA Is Regulated by HuR, and This Activity Is Dysregulated in Cancer. Mol. Cell. Biol. 29: 1152-1162 [Abstract] [Full Text]  
  • Grech, G., Blazquez-Domingo, M., Kolbus, A., Bakker, W. J., Mullner, E. W., Beug, H., von Lindern, M. (2008). Igbp1 is part of a positive feedback loop in stem cell factor-dependent, selective mRNA translation initiation inhibiting erythroid differentiation. Blood 112: 2750-2760 [Abstract] [Full Text]  
  • Hassane, D. C., Guzman, M. L., Corbett, C., Li, X., Abboud, R., Young, F., Liesveld, J. L., Carroll, M., Jordan, C. T. (2008). Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data. Blood 111: 5654-5662 [Abstract] [Full Text]  
  • Culjkovic, B., Tan, K., Orolicki, S., Amri, A., Meloche, S., Borden, K. L.B. (2008). The eIF4E RNA regulon promotes the Akt signaling pathway. JCB 181: 51-63 [Abstract] [Full Text]  
  • Guzman, M. L., Rossi, R. M., Neelakantan, S., Li, X., Corbett, C. A., Hassane, D. C., Becker, M. W., Bennett, J. M., Sullivan, E., Lachowicz, J. L., Vaughan, A., Sweeney, C. J., Matthews, W., Carroll, M., Liesveld, J. L., Crooks, P. A., Jordan, C. T. (2007). An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells. Blood 110: 4427-4435 [Abstract] [Full Text]  
  • Culjkovic, B., Topisirovic, I., Skrabanek, L., Ruiz-Gutierrez, M., Borden, K. L.B. (2006). eIF4E is a central node of an RNA regulon that governs cellular proliferation. JCB 175: 415-426 [Abstract] [Full Text]  
  • Larsson, O., Perlman, D. M., Fan, D., Reilly, C. S., Peterson, M., Dahlgren, C., Liang, Z., Li, S., Polunovsky, V. A., Wahlestedt, C., Bitterman, P. B. (2006). Apoptosis resistance downstream of eIF4E: posttranscriptional activation of an anti-apoptotic transcript carrying a consensus hairpin structure. Nucleic Acids Res 34: 4375-4386 [Abstract] [Full Text]  
  • Blazquez-Domingo, M., Grech, G., von Lindern, M. (2005). Translation Initiation Factor 4E Inhibits Differentiation of Erythroid Progenitors. Mol. Cell. Biol. 25: 8496-8506 [Abstract] [Full Text]  
  • Culjkovic, B., Topisirovic, I., Skrabanek, L., Ruiz-Gutierrez, M., Borden, K. L.B. (2005). eIF4E promotes nuclear export of cyclin D1 mRNAs via an element in the 3'UTR. JCB 169: 245-256 [Abstract] [Full Text]  
  • Djavani, M., Topisirovic, I., Zapata, J. C., Sadowska, M., Yang, Y., Rodas, J., Lukashevich, I. S., Bogue, C. W., Pauza, C. D., Borden, K. L. B., Salvato, M. S. (2005). The Proline-Rich Homeodomain (PRH/HEX) Protein Is Down-Regulated in Liver during Infection with Lymphocytic Choriomeningitis Virus. J. Virol. 79: 2461-2473 [Abstract] [Full Text]  
  • Topisirovic, I., Kentsis, A., Perez, J. M., Guzman, M. L., Jordan, C. T., Borden, K. L. B. (2005). Eukaryotic Translation Initiation Factor 4E Activity Is Modulated by HOXA9 at Multiple Levels. Mol. Cell. Biol. 25: 1100-1112 [Abstract] [Full Text]  
  • Kentsis, A., Topisirovic, I., Culjkovic, B., Shao, L., Borden, K. L. B. (2004). Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap. Proc. Natl. Acad. Sci. USA 101: 18105-18110 [Abstract] [Full Text]  
  • Topisirovic, I., Ruiz-Gutierrez, M., Borden, K. L. B. (2004). Phosphorylation of the Eukaryotic Translation Initiation Factor eIF4E Contributes to Its Transformation and mRNA Transport Activities. Cancer Res. 64: 8639-8642 [Abstract] [Full Text]  
  • Swingler, T. E., Bess, K. L., Yao, J., Stifani, S., Jayaraman, P.-S. (2004). The Proline-rich Homeodomain Protein Recruits Members of the Groucho/Transducin-like Enhancer of Split Protein Family to Co-repress Transcription in Hematopoietic Cells. J. Biol. Chem. 279: 34938-34947 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»